Table 2.
a. Performance of third- and fourth-generation IA, and the current and alternative laboratory HIV testing algorithms among 230 specimens from HIV-1 seroconverters | ||||||
---|---|---|---|---|---|---|
Multispot | Western blot | |||||
NR | R | negative | indeterminate | positive | ||
Third-generation screening | ||||||
R | n= 102 | 12 | 90 | 11 | 35 | 56 |
NAT negative | 0 | 4† | 0 | 1† | 3† | |
NAT positive | 12 | 86 | 11 | 34 | 53 | |
NR | n= 128 | 128 | 0 | n/d | n/d | n/d |
Fourth-generation screening | ||||||
R | n=131 | 41 | 90 | 36 | 39 | 56 |
NAT negative | 1 | 4† | 1 | 1† | 3† | |
NAT positive | 40 | 86 | 35 | 38 | 53 | |
NR | n=99 | 99 | 0 | n/d | n/d | n/d |
b. Number of specimens detected by the current and alternative laboratory HIV testing algorithm among 26 HIV-1 seroconverters (230 specimens) | ||
---|---|---|
Screening IA | MS/NAT | WB |
Third-generation | 102* ** | 56** |
Fourth-generation | 130* ** | 56** |
Same specimens, and had been obtained subsequent to NAT-positive specimens from the same seroconverters
The table shows the number of specimens detected by the combination of different tests in the context of the current and alternative laboratory.
HIV testing algorithm including nucleic acid testing (NAT); n: number; n/d: not determined; NR: non-reactive; R: reactive; NAT: nucleic acid test
p< 0.001 (102 vs. 130);
p< 0.001 (102 vs. 56 and 130 vs. 56).
MS: Multispot; NAT: nucleic acid test; WB: Western blot*